Join
Live feed
·
SECFilingvia Quantisnow
PhaseBio Pharmaceuticals Inc. logo

PhaseBio Pharmaceuticals Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial Statements and Exhibits

ByQuantisnow·Wall Street's wire, on your screen.
PHAS· PhaseBio Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PHAS (PhaseBio Pharmaceuticals Inc.) and more on Quantisnow.